Noveris Health Sciences is trading 6.7% lower at CA$0.07, with no company-specific announcement explaining the October 7, 2026 decline.
- The latest company news found was its September 9 meeting-results announcement.
- Biotech weakness may be a supporting factor: XBI was down 2.50% alongside a broadly weaker market, though the available evidence does not establish a direct cause.
- No trading-volume details were available.